The R132H mutation in IDH 1 promotes the recruitment of NK cells through CX 3 CL 1/ CX 3 CR 1 chemotaxis and is correlated with a better prognosis in gliomas-Reference-Cited by-同舟云学术

The R132H mutation in IDH 1 promotes the recruitment of NK cells through CX 3 CL 1/ CX 3 CR 1 chemotaxis and is correlated with a better prognosis in gliomas

Published:2019-01-25 Issue:5 Volume:97 Page:457-469
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Ren Feifei¹²,Zhao Qitai¹,Huang Lan¹,Zheng Yujia¹,Li Lifeng¹,He Qianyi¹³,Zhang Chaoqi¹,Li Feng¹,Maimela Nomathamsanqa R¹,Sun Zhi⁴,Jia Qingquan⁴,Ping Yu¹,Zhang Zhen¹,Chen Xinfeng¹,Yue Ying¹⁵,Liu Shasha¹,Cao Ling¹,Zhang Yi¹²⁶⁷^ORCID

Affiliation:

1. Biotherapy Center The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan 450052 China

2. School of Life Sciences Zhengzhou University Zhengzhou Henan 450052 China

3. Department of Neurology The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan 450052 China

4. Department of Pharmacy The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan 450052 China

5. The No. 7 People's Hospital of Zhengzhou Zhengzhou Henan 450052 China

6. Cancer Center The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan 450052 China

7. Henan Key Laboratory for Tumor Immunology and Biotherapy Zhengzhou Henan 450052 China

Funder

National Natural Science Foundation of China

Zhengzhou University

Chinese Academy of Sciences

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imcb.12225

Reference56 articles.

1. The 2007 WHO Classification of Tumours of the Central Nervous System

2. The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years

3. Different molecular patterns in glioblastoma multiforme subtypes upon recurrence

4. An Integrated Genomic Analysis of Human Glioblastoma Multiforme

5. Molecular pathogenesis of IDH mutations in gliomas

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges;Cancer Letters;2024-09

2. Natural killer cells and engagers: Powerful weapons against cancer;Immunological Reviews;2024-08-24

3. Fractalkine in Health and Disease;International Journal of Molecular Sciences;2024-07-23

4. Tumor Metabolism: A New Field for the Treatment of Glioma;Bioconjugate Chemistry;2024-07-16

5. CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity;Frontiers in Immunology;2024-07-01